Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/75839
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: Investigating a cluster of vulvar cancer in young women: a cross-sectional study of genital human papillomavirus prevalence
Author: Rumbold, A.
Tan, S.
Condon, J.
Taylor-Thomson, D.
Nickels, M.
Tabrizi, S.
Davy, M.
O'Brien, M.
Connors, C.
Zardawi, I.
Stankovich, J.
Garland, S.
Citation: BMC Infectious Diseases, 2012; 12(1):1-8
Publisher: BioMed Central Ltd
Issue Date: 2012
ISSN: 1471-2334
1471-2334
Statement of
Responsibility: 
Alice R Rumbold, Sarah E Tan, John R Condon, Debbie Taylor-Thomson, Maria Nickels, Sepehr N Tabrizi, Margaret LJ Davy, Margaret M O’Brien, Christine M Connors, Ibrahim Zardawi, Jim Stankovich and Suzanne M Garland
Abstract: Background: Vulvar cancer is a relatively rare malignancy, which occurs most often in postmenopausal women. We have previously identified a geographic cluster of vulvar cancer in young Indigenous women living in remote communities in the Arnhem Land region of Australia. In this population, we investigated the prevalence of oncogenic human papillomavirus (HPV) infection in anogenital samples (vulvar/vaginal/perianal area and cervix) and compared the overall, type-specific and multiple infection prevalence between sites. Methods: A cross-sectional survey of 551 Indigenous women aged 18–60 years was undertaken in 9 Arnhem Land communities. Women were consented for HPV detection and genotyping collected by a combined vulvar/vaginal/perianal (VVP) sweep swab and a separate PreservCyt endocervical sample collected during Pap cytology screening. HPV DNA testing was undertaken using PCR with broad spectrum L1 consensus PGMY09/11 primers with genotyping of positive samples by Roche Linear Array. The primary outcomes were the prevalence of cervical and VVP high-risk (HR) HPV. Results: The prevalence of VVP HR-HPV was 39%, which was significantly higher than the cervical HR-HPV prevalence (26%, p<0.0001). HPV-16 was the most common genotype detected in both sites (VVP 11%, cervical 6%). HPV-16 infection peaked in women aged <20 years; however, there was a marked decline in cervical HPV-16 prevalence with age (p=0.007), whereas following an initial decline, the prevalence of VVP HPV-16 remained constant in subsequent age-groups (p=0.835). Conclusions: In this population experiencing a cluster of vulvar cancer, the prevalence of cervical oncogenic HPV infection was similar to that reported by studies of other Australian women; however there was a significantly higher prevalence of vulvar/vaginal/perianal infection to cervical. The large discrepancy in HPV prevalence between anogenital sites in this population may represent more persistent infection at the vulva. This needs further investigation, including the presence of possible environmental and/or genetic factors that may impair host immunity.
Keywords: Human papillomavirus
Population prevalence
Vulvar neoplasms
Young women
Indigenous women
Description: The electronic version of this article is the complete one and can be found online at: http://www.biomedcentral.com/1471-2334/12/243 Extent: 8p.
Rights: © 2012 Rumbold et al.; licensee BioMed Central Ltd.This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
DOI: 10.1186/1471-2334-12-243
Published version: http://dx.doi.org/10.1186/1471-2334-12-243
Appears in Collections:Aurora harvest 4
Obstetrics and Gynaecology publications

Files in This Item:
File Description SizeFormat 
hdl_75839.pdfPublished version255.78 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.